Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 707

1.

Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know.

Schwartz M, Brandel JP, Babonneau ML, Boucher C, Schaerer E, Haik S, Laplanche JL, Gargiulo M, Durr A.

Front Genet. 2019 Sep 20;10:895. doi: 10.3389/fgene.2019.00895. eCollection 2019.

2.

Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS).

Roosenhoff R, Reed V, Kenwright A, Schutten M, Boucher CA, Monto A, Clinch B, Kumar D, Whitley R, Nguyen-Van-Tam JS, Osterhaus ADME, Fouchier RAM, Fraaij PLA.

Clin Infect Dis. 2019 Sep 27. pii: ciz939. doi: 10.1093/cid/ciz939. [Epub ahead of print]

PMID:
31560055
3.

Characterization of the Microbial Resistome in Conventional and "Raised Without Antibiotics" Beef and Dairy Production Systems.

Rovira P, McAllister T, Lakin SM, Cook SR, Doster E, Noyes NR, Weinroth MD, Yang X, Parker JK, Boucher C, Booker CW, Woerner DR, Belk KE, Morley PS.

Front Microbiol. 2019 Sep 4;10:1980. doi: 10.3389/fmicb.2019.01980. eCollection 2019.

4.

Building large updatable colored de Bruijn graphs via merging.

Muggli MD, Alipanahi B, Boucher C.

Bioinformatics. 2019 Jul 15;35(14):i51-i60. doi: 10.1093/bioinformatics/btz350.

5.

Fast and Accurate Correction of Optical Mapping Data via Spaced Seeds.

Salmela L, Mukherjee K, Puglisi SJ, Muggli MD, Boucher C.

Bioinformatics. 2019 Sep 3. pii: btz663. doi: 10.1093/bioinformatics/btz663. [Epub ahead of print]

PMID:
31504206
6.

Sequencing Technologies and Analyses: Where Have We Been and Where Are We Going?

Bansal V, Boucher C.

iScience. 2019 Aug 30;18:37-41. doi: 10.1016/j.isci.2019.06.035. Epub 2019 Aug 15.

7.

Hierarchical Hidden Markov models enable accurate and diverse detection of antimicrobial resistance sequences.

Lakin SM, Kuhnle A, Alipanahi B, Noyes NR, Dean C, Muggli M, Raymond R, Abdo Z, Prosperi M, Belk KE, Morley PS, Boucher C.

Commun Biol. 2019 Aug 6;2:294. doi: 10.1038/s42003-019-0545-9. eCollection 2019.

8.

Regulation of outer-membrane proteins (OMPs) A and F, during hlyF-induced outer-membrane vesicle (OMV) biosynthesis.

van der Westhuizen WA, Theron CW, Boucher CE, Bragg RR.

Heliyon. 2019 Jul 1;5(7):e02014. doi: 10.1016/j.heliyon.2019.e02014. eCollection 2019 Jul.

9.

Identification of co-evolving temporal networks.

Elhesha R, Sarkar A, Boucher C, Kahveci T.

BMC Genomics. 2019 Jun 13;20(Suppl 6):434. doi: 10.1186/s12864-019-5719-9.

10.

Prefix-free parsing for building big BWTs.

Boucher C, Gagie T, Kuhnle A, Langmead B, Manzini G, Mun T.

Algorithms Mol Biol. 2019 May 24;14:13. doi: 10.1186/s13015-019-0148-5. eCollection 2019.

11.

Genomic Comparison Reveals Natural Occurrence of Clinically Relevant Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Escherichia coli Strains.

Teng L, Lee S, Ginn A, Markland SM, Mir RA, DiLorenzo N, Boucher C, Prosperi M, Johnson J, Morris JG Jr, Jeong KC.

Appl Environ Microbiol. 2019 Jun 17;85(13). pii: e03030-18. doi: 10.1128/AEM.03030-18. Print 2019 Jul 1.

PMID:
31053578
12.

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals.

Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O, Sypsa V, Morgan T, Gamkrelidze A, Mukabatsinda C, Deuffic-Burban S, Ninburg M, Feld J, Hellard M, Ward J.

J Virus Erad. 2019 Jan 1;5(1):60-66.

13.

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058.

van de Vijver DAMC, Richter AK, Boucher CAB, Gunsenheimer-Bartmeyer B, Kollan C, Nichols BE, Spinner CD, Wasem J, Schewe K, Neumann A.

Euro Surveill. 2019 Feb;24(7). doi: 10.2807/1560-7917.ES.2019.24.7.1800398.

14.

Aligning optical maps to de Bruijn graphs.

Mukherjee K, Alipanahi B, Kahveci T, Salmela L, Boucher C.

Bioinformatics. 2019 Sep 15;35(18):3250-3256. doi: 10.1093/bioinformatics/btz069.

PMID:
30698651
15.

Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men.

Popping S, Hullegie SJ, Boerekamps A, Rijnders BJA, de Knegt RJ, Rockstroh JK, Verbon A, Boucher CAB, Nichols BE, van de Vijver DAMC.

PLoS One. 2019 Jan 10;14(1):e0210179. doi: 10.1371/journal.pone.0210179. eCollection 2019.

16.

Deletion in 2q35 excluding the IHH gene leads to fetal severe limb anomalies and suggests a disruption of chromatin architecture.

Trimouille A, Tingaud-Sequeira A, Pennamen P, André G, Bouron J, Boucher C, Fergelot P, Lacombe D, Arveiler B, Rooryck C.

Eur J Hum Genet. 2019 Mar;27(3):384-388. doi: 10.1038/s41431-018-0290-4. Epub 2018 Oct 29.

PMID:
30374058
17.

Detection of virulence factors of South African Lactococcus garvieae isolated from rainbow trout, Oncorhynchus mykiss (Walbaum).

Meyburgh CM, Bragg RR, Boucher CE.

Onderstepoort J Vet Res. 2018 Oct 4;85(1):e1-e9. doi: 10.4102/ojvr.v85i1.1568.

18.

Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy.

Wijting I, Rutsaert SL, Rokx C, Burger DM, Verbon A, van Kampen J, Boucher C, Rijnders B, Vandekerckhove L.

HIV Med. 2019 Jan;20(1):63-68. doi: 10.1111/hiv.12675. Epub 2018 Sep 30.

19.

A Summary of the Third Annual HIV Microbiome Workshop.

Williams B, Boucher C, Bushman F, Carrington-Lawrence S, Collman R, Dandekar S, Dang Q, Malaspina A, Paredes R, Wilson C, Nowak P, Klatt N, Lagenaur L, Landay A.

AIDS Res Hum Retroviruses. 2018 Oct;34(10):828-834. doi: 10.1089/AID.2018.0103. Epub 2018 Oct 9.

20.

Investigating Effects of Tulathromycin Metaphylaxis on the Fecal Resistome and Microbiome of Commercial Feedlot Cattle Early in the Feeding Period.

Doster E, Rovira P, Noyes NR, Burgess BA, Yang X, Weinroth MD, Lakin SM, Dean CJ, Linke L, Magnuson R, Jones KI, Boucher C, Ruiz J, Belk KE, Morley PS.

Front Microbiol. 2018 Jul 30;9:1715. doi: 10.3389/fmicb.2018.01715. eCollection 2018.

21.

Reply to Darcis and Berkhout.

Wijting IEA, Lungu C, Rijnders BJA, van der Ende ME, Pham HT, Mesplede T, Pas SD, Voermans JJC, Schuurman R, van de Vijver DAMC, Boers PHM, Gruters RA, Boucher CAB, van Kampen JJA.

J Infect Dis. 2018 Nov 5;218(12):2020-2021. doi: 10.1093/infdis/jiy475. No abstract available.

PMID:
30085047
22.
23.

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C.

Popping S, Cento V, García F, Ceccherini-Silberstein F, Seguin-Devaux C, Vijver DA, Boucher CA.

J Virus Erad. 2018 Jul 1;4(3):179-181.

24.

Cyclooxygenases and lipoxygenases are used by the fungus Podospora anserina to repel nematodes.

Ferrari R, Lacaze I, Le Faouder P, Bertrand-Michel J, Oger C, Galano JM, Durand T, Moularat S, Chan Ho Tong L, Boucher C, Kilani J, Petit Y, Vanparis O, Trannoy C, Brun S, Lalucque H, Malagnac F, Silar P.

Biochim Biophys Acta Gen Subj. 2018 Oct;1862(10):2174-2182. doi: 10.1016/j.bbagen.2018.07.012. Epub 2018 Jul 17.

PMID:
30025856
25.

Comparative efficacy of three antiseptics as surgical skin preparations in dogs.

Boucher C, Henton MM, Becker PJ, Kirberger RM, Hartman MJ.

Vet Surg. 2018 Aug;47(6):792-801. doi: 10.1111/vsu.12913. Epub 2018 Jul 13.

PMID:
30004127
26.

Practical dynamic de Bruijn graphs.

Crawford VG, Kuhnle A, Boucher C, Chikhi R, Gagie T.

Bioinformatics. 2018 Dec 15;34(24):4189-4195. doi: 10.1093/bioinformatics/bty500.

PMID:
29939217
27.

New role of P2X7 receptor in an Alzheimer's disease mouse model.

Martin E, Amar M, Dalle C, Youssef I, Boucher C, Le Duigou C, Brückner M, Prigent A, Sazdovitch V, Halle A, Kanellopoulos JM, Fontaine B, Delatour B, Delarasse C.

Mol Psychiatry. 2019 Jan;24(1):108-125. doi: 10.1038/s41380-018-0108-3. Epub 2018 Jun 22.

28.

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR).

BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2.

29.

Error correcting optical mapping data.

Mukherjee K, Washimkar D, Muggli MD, Salmela L, Boucher C.

Gigascience. 2018 Jun 1;7(6). doi: 10.1093/gigascience/giy061.

30.

Selection of Avibacterium paragallinarum Page serovar B strains for an infectious coryza vaccine.

Sun H, Xie S, Li X, Xu F, Li Y, Boucher CE, Chen X.

Vet Immunol Immunopathol. 2018 May;199:77-80. doi: 10.1016/j.vetimm.2018.04.001. Epub 2018 Apr 5.

PMID:
29678233
31.

Counting motifs in dynamic networks.

Mukherjee K, Hasan MM, Boucher C, Kahveci T.

BMC Syst Biol. 2018 Apr 11;12(Suppl 1):6. doi: 10.1186/s12918-018-0533-6.

32.

State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap.

Boucher CA, Bobkova MR, Geretti AM, Hung CC, Kaiser R, Marcelin AG, Streinu-Cercel A, van Wyk J, Dorr P, Vandamme AM.

AIDS Rev. 2018 Jan-Mar;20(1):27-42. Review.

PMID:
29628515
33.

State of the Art in HIV Drug Resistance: Surveillance and Regional Gaps.

Boucher CA, Bobkova MR, Hung CC, Kaiser R, Marcelin AG, Streinu-Cercel A, van Wyk J, Dorr P, Vandamme AM.

AIDS Rev. 2018 Jan-Mar;20(1):43-57. Review.

PMID:
29628514
34.

The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors.

Pham HT, Labrie L, Wijting IEA, Hassounah S, Lok KY, Portna I, Goring ME, Han Y, Lungu C, van der Ende ME, Brenner BG, Boucher CA, Rijnders BJA, van Kampen JJA, Mesplède T, Wainberg MA.

J Infect Dis. 2018 Jul 24;218(5):698-706. doi: 10.1093/infdis/jiy175.

35.

HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy.

Wijting IEA, Lungu C, Rijnders BJA, van der Ende ME, Pham HT, Mesplede T, Pas SD, Voermans JJC, Schuurman R, van de Vijver DAMC, Boers PHM, Gruters RA, Boucher CAB, van Kampen JJA.

J Infect Dis. 2018 Jul 24;218(5):688-697. doi: 10.1093/infdis/jiy176.

PMID:
29617822
36.

A quality improvement project to increase self-administration of medicines in an acute hospital.

Garfield S, Bell H, Nathan C, Randall S, Husson F, Boucher C, Taylor A, Lloyd J, Backhouse A, Ritchie L, Franklin BD.

Int J Qual Health Care. 2018 Jun 1;30(5):396-407. doi: 10.1093/intqhc/mzy035.

37.

A General Framework for 3-D Parameters Estimation of Roads Using GPS, OSM and DEM Data.

Boucher C, Noyer JC.

Sensors (Basel). 2017 Dec 25;18(1). pii: E41. doi: 10.3390/s18010041.

38.

Insights on transmission of HIV from phylogenetic analysis to locally optimize HIV prevention strategies.

van de Vijver DAMC, Boucher CAB.

Curr Opin HIV AIDS. 2018 Mar;13(2):95-101. doi: 10.1097/COH.0000000000000443. Review.

PMID:
29266012
39.

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.

Lina B, Boucher C, Osterhaus A, Monto AS, Schutten M, Whitley RJ, Nguyen-Van-Tam JS.

Influenza Other Respir Viruses. 2018 Mar;12(2):267-278. doi: 10.1111/irv.12534. Epub 2018 Jan 15.

40.

Ending the epidemic: Critical role of primary HIV infection.

Prins HAB, Verbon A, Boucher CAB, Rokx C.

Neth J Med. 2017 Oct;75(8):321-327. Review.

41.

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.

Boerekamps A, van den Berk GE, Lauw FN, Leyten EM, van Kasteren ME, van Eeden A, Posthouwer D, Claassen MA, Dofferhoff AS, Verhagen DWM, Bierman WF, Lettinga KD, Kroon FP, Delsing CE, Groeneveld PH, Soetekouw R, Peters EJ, Hullegie SJ, Popping S, van de Vijver DAMC, Boucher CA, Arends JE, Rijnders BJ.

Clin Infect Dis. 2018 Apr 17;66(9):1360-1365. doi: 10.1093/cid/cix1007.

PMID:
29186320
42.

19p13 microduplications encompassing NFIX are responsible for intellectual disability, short stature and small head circumference.

Trimouille A, Houcinat N, Vuillaume ML, Fergelot P, Boucher C, Toutain J, Caignec CL, Vincent M, Nizon M, Andrieux J, Vanlerberghe C, Delobel B, Duban B, Mansour S, Baple E, McKeown C, Poke G, Robertshaw K, Fifield E, Fabretto A, Pecile V, Gasparini P, Carrozzi M, Lacombe D, Arveiler B, Rooryck C, Moutton S.

Eur J Hum Genet. 2018 Jan;26(1):85-93. doi: 10.1038/s41431-017-0037-7. Epub 2017 Nov 28.

43.

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial.

Wijting I, Rokx C, Boucher C, van Kampen J, Pas S, de Vries-Sluijs T, Schurink C, Bax H, Derksen M, Andrinopoulou ER, van der Ende M, van Gorp E, Nouwen J, Verbon A, Bierman W, Rijnders B.

Lancet HIV. 2017 Dec;4(12):e547-e554. doi: 10.1016/S2352-3018(17)30152-2. Epub 2017 Oct 26.

PMID:
29107562
44.

Enrichment allows identification of diverse, rare elements in metagenomic resistome-virulome sequencing.

Noyes NR, Weinroth ME, Parker JK, Dean CJ, Lakin SM, Raymond RA, Rovira P, Doster E, Abdo Z, Martin JN, Jones KL, Ruiz J, Boucher CA, Belk KE, Morley PS.

Microbiome. 2017 Oct 17;5(1):142. doi: 10.1186/s40168-017-0361-8.

45.

Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.

Godfrey C, Bobkova M, Boucher C, Ravasi G, Chen P, Zhang F, Wu Y, Kantor R.

J Infect Dis. 2017 Dec 1;216(suppl_9):S816-S819. doi: 10.1093/infdis/jix408.

46.

A Summary of the Second Annual HIV Microbiome Workshop.

Williams B, Ghosh M, Boucher CAB, Bushman F, Carrington-Lawrence S, Collman RG, Dandekar S, Dang Q, Malaspina A, Paredes R, Wilson CC, Nowak P, Klatt NR, Lagenaur L, Landay AL.

AIDS Res Hum Retroviruses. 2017 Dec;33(12):1258-1264. doi: 10.1089/aid.2017.0137. Epub 2017 Oct 26.

47.

First female prenatal case of osteopathia striata with cranial sclerosis in a fetus carrying a de-novo 1.9 Mbp interstitial deletion at Xq11.1q11.2.

Vuillaume ML, Valard AG, Houcinat N, Bouron J, Boucher C, Deves S, Toutain J, Schaub B, Adenet C, Lacombe D, Gueneret M, Rooryck C.

Clin Dysmorphol. 2017 Oct;26(4):231-234. doi: 10.1097/MCD.0000000000000192. No abstract available.

PMID:
28799946
48.

Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients.

Raj VS, Hundie GB, Schürch AC, Smits SL, Pas SD, Le Pogam S, Janssen HLA, de Knegt RJ, Osterhaus ADME, Najera I, Boucher CA, Haagmans BL.

Sci Rep. 2017 Jul 5;7(1):4688. doi: 10.1038/s41598-017-04931-y.

49.

Methodological concerns regarding a PrEP model - Authors' reply.

Nichols BE, Boucher CAB, van de Vijver DAM.

Lancet Infect Dis. 2017 May;17(5):482-483. doi: 10.1016/S1473-3099(17)30205-0. No abstract available.

PMID:
28447955
50.

Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon.

Hankins CA, Koulla-Shiro S, Kilmarx P, Ferrari G, Schechter M, Kane CT, Venter F, Boucher CA, Ross AL, Zewdie D, Eholié SP, Katabira E.

Antivir Ther. 2017;22(2):179-184. doi: 10.3851/IMP3165. Epub 2017 Apr 7.

Supplemental Content

Loading ...
Support Center